Sponsor:
Eli Lilly and Company
Code:
NCT07483073
Conditions
Colitis, Ulcerative
Crohn Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Mirikizumab - Intravenous (IV)
Mirikizumab - Subcutaneous (SC)
LY4395089
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2026-05-19.